Zuellig Pharma Korea, “We will help Korean pharmaceuticals to expand foreign markets”
Zuellig Pharma Korea announced a position to provide help for innovative pharmaceutical products developed by domestic pharmaceutical companies to enter foreign markets.
In fact, Zeullig Pharma Korea has played an essential role in establishing the license agreement of ‘Kanarb,’ a Boryung Pharm’...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
